Market Place
Sourcing Support
Eurofins CDMO Alphora to Build GMP Biologics Manufacturing Facility
24 Sep 2024 //
BUSINESSWIRE
Eurofins CDMO Alphora Completes New API Manufacturing Facility
09 Jul 2024 //
BUSINESSWIRE
Eurofins Acquires Labormar, Expands Testing Services In Latin America
08 Jul 2024 //
BUSINESSWIRE
Eurofins CDMO Alphora Launches Expanded Drug Product Analytical Laboratory
19 Jun 2024 //
CONTRACT PHARMA
Eurofins CDMO Alphora Launches Expanded Analytical Drug Product Lab
29 May 2024 //
BUSINESSWIRE
Eurofins E&E and ETS-Lindgren Complete Half-Million-Dollar Expansion
29 Feb 2024 //
BUSINESSWIRE
Eurofins Discovery Introduces Innovative DiscoveryAI SAFIRE
29 Feb 2024 //
BUSINESSWIRE
Eurofins CDMO Alphora announces completion of a new pilot biologics facility
27 Feb 2024 //
PRESS RELEASE
Eurofins Announces the Completion of Pilot Scale Biologics Development Facility
17 Jan 2024 //
BUSINESSWIRE
Eurofins Scientific Announces the Acquisition of Labor 3
16 Nov 2023 //
BUSINESSWIRE
Health Canada Approves Alphora Cannabis License for Synthetic Phytocannabinoids
11 Oct 2023 //
BUSINESSWIRE
Eurofins CDMO Announces the Launch of its Biologics Initiative focusing on mAbs
04 Oct 2023 //
BUSINESSWIRE
Mainz Biomed Announces Addition of Eurofins GeLaMed to its Growing Network
03 May 2023 //
GLOBENEWSWIRE
Eurofins fully compensates for the decline in COVID-19 testing in 2022
01 Mar 2023 //
PRESS RELEASE
Eurofins Companies Launch SARS-CoV-2 Variant XBB.1.5 ddPCR
20 Feb 2023 //
BUSINESSWIRE
Eurofins CDMO Alphora Expands API Development Labs
13 Jan 2023 //
CONTRACT PHARMA
Incannex Engages Eurofins to Manufacture Topical Therapeutic ReneCann
30 Nov 2022 //
CONTRACTPHARMA
Incannex, Eurofins Enter Development & Mfg. Pact for Addiction Disorder Meds
28 Nov 2022 //
CONTRACT PHARMA
Incannex to manufacture patented medicated chewable anti-addiction products
25 Nov 2022 //
SMALLCAPS
Eurofins Signs a Multiyear Collaboration With St. Josephs University, Bangalore
24 Nov 2022 //
BUSINESSWIREINDIA
Eurofins Successfully Prices New €600m 7-Year 4%-Coupon Senior Unsecured Bonds
21 Jun 2022 //
BUSINESSWIRE
Eurofins bioskin is delighted to celebrate 30 years
12 May 2022 //
PRESS RELEASE
Health Canada approves Eurofins CDMO Alphora Inc.’s Standard Processing License
10 May 2022 //
BUSINESSWIRE
PAMM Foundation Outsources Its Laboratory Activities for PAMM to Eurofins
09 May 2022 //
BUSINESSWIRE
Eurofins Genomics Will Be Conducting Genotyping for up to 5M Participants
08 Mar 2022 //
BUSINESSWIRE
Eurofins CDMO helps solve the rising challenge of colon drug delivery for biologics
22 Feb 2022 //
PRESS RELEASE
Eurofins to Acquire Genetic Testing Service JSC, Enter Genetic Testing Market
09 Feb 2022 //
BUSINESSWIRE
Eurofins’ empowerDX launches PFAS Exposure in the U.S
21 Jan 2022 //
BUSINESSWIRE
Eurofins CDMO Expands Spray Drying Capabilities
11 Jan 2022 //
BUSINESSWIRE
Gold Standard Diagnostics, a Eurofins Technologies company, launches CE marked
14 Dec 2021 //
PRESS RELEASE
Eurofins Enhances COVID-19 Testing Offering Through Acquisition of Genetic Lab
10 Dec 2021 //
BUSINESSWIRE
Eurofins Environment Testing Launches PFAS Exposure™ Self-Collection Blood Test
01 Dec 2021 //
BUSINESSWIRE
Eurofins will be part of the CAC 40 from September 17
10 Sep 2021 //
BUSINESSWIRE
Eurofins Will Be Included in the CAC 40 Index From September 17
09 Sep 2021 //
BUSINESSWIRE
Eurofins is expanding its network of COVID-19 screening centers
12 Aug 2021 //
BUSINESSWIRE
Eurofins Strengthens Its Global Leadership Position in Cosmetics
04 Aug 2021 //
BUSINESSWIRE
Eurofins consolidates its position as a world leader in the analysis
04 Aug 2021 //
BUSINESSWIRE
Eurofins Abraxis Announces the World’s First Rapid Glyphosate Method
29 Jul 2021 //
BUSINESSWIRE
Eurofins and Rite Aid Launch FDA-Authorised, at-Home COVID-19 PCR Test
09 Jul 2021 //
BUSINESSWIRE
Eurofins and Rite Aid launch FDA-cleared, over-the-counter, home-based PCR test
09 Jul 2021 //
BUSINESSWIRE
Eurofins Viracor Invests in Innovation with the Launch of Coronavirus
07 Jul 2021 //
BUSINESSWIRE
Eurofins Develops Most Comprehensive COVID-19 Testing Network in the UK
02 Jul 2021 //
BUSINESSWIRE
Eurofins verdubbelt Europees netwerk van SARS-CoV-2 (COVID-19) testlocatie
02 Jul 2021 //
BUSINESSWIRE
Eurofins is developing an efficient network of SARS-CoV-2 screening centers
02 Jul 2021 //
BUSINESSWIRE
Eurofins Opens Europe-Wide COVID-19 Testing Centre Network
01 Jul 2021 //
BUSINESSWIRE
Eurofins Develops Most Comprehensive COVID-19 Testing Network
01 Jul 2021 //
BUSINESSWIRE
Eurofins doubles European network of SARS-CoV-2 (COVID-19) test site
01 Jul 2021 //
BUSINESSWIRE
Eurofins developing the most comprehensive network of SARS-CoV-2 test centers
01 Jul 2021 //
BUSINESSWIRE
DNA Diagnostics Center Agrees to Join Eurofins via Acquisition
28 Jun 2021 //
BIO SPACE
Eurofins Discovery inks agreement with ImmunoPrecise
23 Jun 2021 //
PHARMABIZ
Eurofins Discovery and ImmunoPrecise announce collaboration
23 Jun 2021 //
BUSINESSWIRE
BetterLife Pharma hires Eurofins CDMO to manufacture LSD derivative TD-0148A
03 Mar 2021 //
PROACTIVEINVESTORS
Eurofins Announces the launch of an At-Home COVID-19 PCR Test kit
28 Feb 2021 //
BUSINESSWIRE
Eurofins Scientific Acquires Beacon Discovery
19 Feb 2021 //
CONTRACTPHARMA
Eurofins Scientific acquires San Diego-based GPCR-focused drug
19 Feb 2021 //
PHARMABIZ
Eurofins to Expand Drug Discovery Capabilities Through Beacon Acquisition
18 Feb 2021 //
PRESS RELEASE
